Résultats de la recherche - Busaidy, Naifa
- Résultat(s) 1 - 20 résultats de 57
- Aller à la page suivante
-
1
-
2
-
3
Unilateral renal artery stenosis with renal atrophy in a patient with metastatic papillary thyroid carcinoma treated with sorafenib par Shawa, Hassan, Busaidy, Naifa L, Schellingerhout, Dawid, Habra, Mouhammed Amir
Publié 2013Texte -
4
-
5
Larotrectinib Before Initial Radioactive Iodine Therapy in Pediatric TRK Fusion–Positive Papillary Thyroid Carcinoma: Time to Reconsider the Treatment Paradigm for Distantly Metast... par Waguespack, Steven G., Tewari, Sanjit O., Busaidy, Naifa L., Zafereo, Mark E.
Publié 2022Texte -
6
Safe and Effective Dosing of Basal–Bolus Insulin in Patients Receiving High-Dose Steroids for Hyper-Cyclophosphamide, Doxorubicin, Vincristine, and Dexamethasone Chemotherapy par Brady, Veronica, Thosani, Sonali, Zhou, Shouhou, Bassett, Roland, Busaidy, Naifa Lamki, Lavis, Victor
Publié 2014Texte -
7
-
8
OR27-6 Combination Vemurafenib (BRAF Inhibitor)/Cobimetinib (MEK Inhibitor)/Atezolizumab (Anti-PDL1 Inhibitor) in BRAF-V600E Mutated Anaplastic Thyroid Cancer (ATC): Initial Safety... par Cabanillas, Maria, Busaidy, Naifa, Dadu, Ramona, Ferrarotto, Renata, Gross, Neil, Gule-Monroe, Maria, Lu, Charles, Grosu, Horiana, Williams, Michelle, Zafereo, Mark
Publié 2019Texte -
9
Management of Metabolic Effects Associated With Anticancer Agents Targeting the PI3K-Akt-mTOR Pathway par Busaidy, Naifa L., Farooki, Azeez, Dowlati, Afshin, Perentesis, John P., Dancey, Janet E., Doyle, Laurence A., Brell, Joanna M., Siu, Lillian L.
Publié 2012Texte -
10
Efficacy of the Natural Clay, Calcium Aluminosilicate Anti-Diarrheal, in Reducing Medullary Thyroid Cancer–Related Diarrhea and Its Effects on Quality of Life: A Pilot Study par Dadu, Ramona, Hu, Mimi I., Cleeland, Charles, Busaidy, Naifa L., Habra, Mouhammed, Waguespack, Steven G., Sherman, Steven I., Ying, Anita, Fox, Patricia, Cabanillas, Maria E.
Publié 2015Texte -
11
Phase I Clinical Trials in 56 Patients with Thyroid Cancer: The M. D. Anderson Cancer Center Experience par Tsimberidou, Apostolia Maria, Vaklavas, Christos, Wen, Sijin, Hong, David, Wheler, Jennifer, Ng, Chaan, Naing, Aung, Tse, Susan, Busaidy, Naifa, Markman, Maurie, Sherman, Steven I., Kurzrock, Razelle
Publié 2009Texte -
12
Cushing's syndrome secondary to ectopic ACTH secretion: The University of Texas MD Anderson Cancer Center Experience par Ejaz, Shamim, Vassilopoulou-Sellin, Rena, Busaidy, Naifa L., Hu, Mimi I., Waguespack, Steven G., Jimenez, Camilo, Ying, Anita K., Cabanillas, Maria, Abbara, Maher, Habra, Mouhammed Amir
Publié 2011Texte -
13
MON-LB015 Sporadic MTC in Children: Characterization of a Rare Disease par Gammons, Sarah, Hu, Mimi I, Zafereo, Mark E, Busaidy, Naifa L, Perrier, Nancy D, Bassett, Roland L, Hyde, Samuel M, Grubbs, Elizabeth G, Waguespack, Steven G
Publié 2020Texte -
14
Acquired Secondary RAS Mutation in BRAF(V600E)-Mutated Thyroid Cancer Patients Treated with BRAF Inhibitors par Cabanillas, Maria E., Dadu, Ramona, Iyer, Pryianka, Wanland, Kacey B., Busaidy, Naifa L., Ying, Anita, Gule-Monroe, Maria, Wang, Jennifer R., Zafereo, Mark, Hofmann, Marie-Claude
Publié 2020Texte -
15
Adjuvant External Beam Radiotherapy in Locally Advanced Differentiated Thyroid Cancer par Tam, Samantha, Amit, Moran, Boonsripitayanon, Mongkol, Cabanillas, Maria E., Busaidy, Naifa L., Gunn, G. Brandon, Lai, Stephen Y., Gross, Neil D., Sturgis, Erich M., Zafereo, Mark E.
Publié 2017Texte -
16
Association of Lymph Node Density With Survival of Patients With Papillary Thyroid Cancer par Amit, Moran, Tam, Samantha, Boonsripitayanon, Mongkol, Cabanillas, Maria E., Busaidy, Naifa L., Grubbs, Elizabeth Gardner, Lai, Stephen Y., Gross, Neil D., Sturgis, Erich M., Zafereo, Mark E.
Publié 2017Texte -
17
Immune-Related Thyroiditis with Immune Checkpoint Inhibitors par Iyer, Priyanka C., Cabanillas, Maria E., Waguespack, Steven G., Hu, Mimi I., Thosani, Sonali, Lavis, Victor R., Busaidy, Naifa L., Subudhi, Sumit K., Diab, Adi, Dadu, Ramona
Publié 2018Texte -
18
Targeted Therapy in Advanced Thyroid Cancer to Resensitize Tumors to Radioactive Iodine par Jaber, Tania, Waguespack, Steven G, Cabanillas, Maria E, Elbanan, Mohamed, Vu, Thinh, Dadu, Ramona, Sherman, Steven I, Amit, Moran, Santos, Elmer B, Zafereo, Mark, Busaidy, Naifa L
Publié 2018Texte -
19
MON-LB097 The Genomic Landscape of Preoperative FNAs Positive for the Afirma GSC Medullary Thyroid Cancer Classifier par Waguespack, Steven, Busaidy, Naifa, Hu, Mimi, Grubbs, Elizabeth, Weitzman, Steven, Wirth, Lori, Zafereo, Mark, Babiarz, Joshua, Hao, Yangyang, Huang, Jing, Kennedy, Giulia, Walsh, P. Sean, Kloos, Richard
Publié 2019Texte -
20
Efficacy and Tolerability of Different Starting Doses of Sorafenib in Patients With Differentiated Thyroid Cancer par Dadu, Ramona, Waguespack, Steven G., Sherman, Steven I., Hu, Mimi I., Busaidy, Naifa L., Jimenez, Camilo, Habra, Mohammed A., Ying, Anita K., Bassett, Roland L., Cabanillas, Maria E.
Publié 2014Texte